Syed R Majid, MD
Hospitalist · Michigan City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Offices
- 2
Offices
2 locations · Smart Physician Systems PC · 8 clinicians in this group
Looking this up.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Majid’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Medicaid work
$666,472 in 2022
Medicaid paid $666,472 for 10,520 billed services this clinician did in 2022, up to 331 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 3,018 | $286,329 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 4,399 | $264,533 |
| Buprenorphine | 636 | $23,595 |
| Measurement of fentanyl | 633 | $23,556 |
| Opioids and opiate analogs; 1 or 2 | 632 | $23,439 |
| Measurement of oxycodone | 528 | $19,656 |
| Short return visit (20+ min) | 155 | $10,929 |
| Measurement of opiate | 428 | $9,711 |
| Tramadol | 75 | $2,574 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 16 | $2,150 |
| 2022 | 10,520 | 10 | 331 | $666,472 |
| 2021 | 16,961 | 16 | 310 | $669,771 |
| 2020 | 845 | 7 | 33 | $37,967 |
| 2019 | 1,015 | 7 | 30 | $25,407 |
| 2018 | 699 | 8 | 24 | $15,063 |
See the largest Medicaid services in earlier years
2021
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 4,647 | $264,679 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,308 | $98,858 |
| Buprenorphine | 2,056 | $57,164 |
| Opioids and opiate analogs; 1 or 2 | 2,060 | $56,707 |
| Measurement of fentanyl | 2,029 | $56,135 |
| Measurement of oxycodone | 1,750 | $47,241 |
| Short return visit (20+ min) | 446 | $34,762 |
| Tramadol | 1,228 | $33,257 |
| Measurement of opiate | 801 | $13,298 |
| Short return visit | 60 | $2,866 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 202 | $2,541 |
| Benzodiazepines; 13 or more | 88 | $650 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 427 | $14,330 |
| Short return visit (20+ min) | 173 | $10,477 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 126 | $6,577 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 54 | $3,427 |
| Return visit (30+ min) | 22 | $2,101 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 24 | $1,055 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 19 | $0 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 428 | $7,820 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 282 | $4,895 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 162 | $4,170 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 68 | $3,069 |
| Short return visit (20+ min) | 43 | $2,941 |
| Return visit (30+ min) | 17 | $1,623 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 15 | $888 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 206 | $4,140 |
| Short return visit (20+ min) | 122 | $3,960 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 116 | $2,614 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 58 | $2,112 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 133 | $1,317 |
| Return visit (30+ min) | 12 | $714 |
| Smoking and tobacco use cessation counseling visit; intensive, greater than 10 minutes | 18 | $188 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 34 | $19 |
Money from drug and device companies
$119 in 2022
| 2022 | 2 | 2 | None | $119 |
| 2021 | 3 | 4 | None | $63 |
| 2020 | 1 | 2 | None | $40 |
| 2019 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 2 published payments
| Neurelis | Meals · 2022-12-13 | Valtoco | $96 |
| Abbvie | Meals · 2022-07-13 | Dalvance | $23 |
See earlier years (2021, 2020, 2019)
2021: $63
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $31 | 2 payments
|
| Almatica Pharma | Naprelan | $18 | 1 payment
|
| Boston Scientific | General Pain Management | $14 | 1 payment
|
2020: $40
| Orexo US | Zubsolv | $40 | 2 payments
|
2019: $23
| Indivior | Sublocade | $23 | 1 payment
|
Professional record
- NPI
- 1225009533
- Licence
- IN 01053114A
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- IN 200297330
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RA0401X (207RA0401X); Hospitalist (208M00000X)
- Mailing address
- 10176 W 400 N Ste C, Michigan City, IN, 46360
- NPI first listed
- 2006-01-27
- NPI last updated
- 2026-03-24
- NPI record certified
- 2026-03-24
This is when the NPI record was last certified, not a medical board exam.